Skip to main content

Peer Review reports

From: Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

Original Submission
15 Mar 2011 Submitted Original manuscript
20 Apr 2011 Reviewed Reviewer Report - Yongzhang Luo
26 Apr 2011 Reviewed Reviewer Report - Steven Akiyama
22 Jun 2011 Author responded Author comments - Ara Hovanessian
Resubmission - Version 2
22 Jun 2011 Submitted Manuscript version 2
28 Jun 2011 Reviewed Reviewer Report - Yongzhang Luo
30 Jul 2011 Author responded Author comments - Ara Hovanessian
Resubmission - Version 3
30 Jul 2011 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
2 Aug 2011 Author responded Author comments - Ara Hovanessian
Resubmission - Version 5
2 Aug 2011 Submitted Manuscript version 5
Publishing
3 Aug 2011 Editorially accepted
3 Aug 2011 Article published 10.1186/1471-2407-11-333

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us